The Complexity of Cardiovascular Long COVID: Where We Are

Overview

Journal Cardiovasc Res

Specialty Cardiology & Vascular Diseases

Date 2024 May 17

PMID 38757616

Authors

Rahul S Gandhi

Betty Raman

Affiliations

Soon will be listed here.

Citing Articles

COVID-19 and Cardiac Arrhythmias: Lesson Learned and Dilemmas.

Blasi F, Vicenzi M, De Ponti R J Clin Med. 2024; 13(23).

PMID: 39685718 PMC: 11642268. DOI: 10.3390/jcm13237259.

References

van der Feltz-Cornelis C, Sweetman J, Allsopp G, Attree E, Crooks M, Cuthbertson D . STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol. PLoS One. 2022; 17(11):e0277936. PMC: 9710789. DOI: 10.1371/journal.pone.0277936. View

Gluckman T, Bhave N, Allen L, Chung E, Spatz E, Ammirati E . 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of.... J Am Coll Cardiol. 2022; 79(17):1717-1756. PMC: 8926109. DOI: 10.1016/j.jacc.2022.02.003. View

Antonelli M, Capdevila Pujol J, Spector T, Ourselin S, Steves C . Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022; 399(10343):2263-2264. PMC: 9212672. DOI: 10.1016/S0140-6736(22)00941-2. View

Sharma A, Garcia Jr G, Wang Y, Plummer J, Morizono K, Arumugaswami V . Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection. Cell Rep Med. 2020; 1(4):100052. PMC: 7323681. DOI: 10.1016/j.xcrm.2020.100052. View

Pessoa-Amorim G, Mafham M . The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19. Cardiovasc Res. 2021; 117(9):e110-e113. PMC: 8318096. DOI: 10.1093/cvr/cvab239. View

Xie Y, Choi T, Al-Aly Z . Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ. 2023; 381:e074572. PMC: 10126525. DOI: 10.1136/bmj-2022-074572. View

Kotanidis C, Xie C, Alexander D, Rodrigues J, Burnham K, Mentzer A . Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19. Lancet Digit Health. 2022; 4(10):e705-e716. PMC: 9417284. DOI: 10.1016/S2589-7500(22)00132-7. View

Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A . Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail. 2020; 7(5):2440-2447. PMC: 7307078. DOI: 10.1002/ehf2.12805. View

Bozkurt B . Shedding Light on Mechanisms of Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2023; 147(11):877-880. PMC: 10010664. DOI: 10.1161/CIRCULATIONAHA.123.063396. View

10.

Bramante C, Buse J, Liebovitz D, Nicklas J, Puskarich M, Cohen K . Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis. 2023; 23(10):1119-1129. PMC: 11259948. DOI: 10.1016/S1473-3099(23)00299-2. View

11.

Al-Aly Z, Bowe B, Xie Y . Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022; 28(7):1461-1467. PMC: 9307472. DOI: 10.1038/s41591-022-01840-0. View

12.

Raman B, Bluemke D, Luscher T, Neubauer S . Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022; 43(11):1157-1172. PMC: 8903393. DOI: 10.1093/eurheartj/ehac031. View

13.

Raisi-Estabragh Z, Cooper J, Salih A, Raman B, Lee A, Neubauer S . Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022; 109(2):119-126. PMC: 9811071. DOI: 10.1136/heartjnl-2022-321492. View

14.

Xie Y, Choi T, Al-Aly Z . Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern Med. 2023; 183(6):554-564. PMC: 10037200. DOI: 10.1001/jamainternmed.2023.0743. View

15.

Arabi M, Al-Najjar Y, Mhaimeed N, Salameh M, Paul P, Alanni J . Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review. J Cell Mol Med. 2023; 27(11):1443-1464. PMC: 10243162. DOI: 10.1111/jcmm.17747. View

16.

Finnigan L, Cassar M, Koziel M, Pradines J, Lamlum H, Azer K . Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study. EClinicalMedicine. 2023; 59:101946. PMC: 10102537. DOI: 10.1016/j.eclinm.2023.101946. View

17.

Davis H, McCorkell L, Vogel J, Topol E . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023; 21(3):133-146. PMC: 9839201. DOI: 10.1038/s41579-022-00846-2. View